2022 Pap Smear/HPV Market Assessment-Global, Regional, China, India
This new report from LeadingMarketResearch.com presents a detailed analysis of the global Pap Smear/HPV testing market, including test volume and sales forecasts for major geographic regions and countries:
The report also presents the Pap Smear and HPV clinical significance and current laboratory practice; examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
- Asia-Pacific
- China
- Europe
- India
- Japan
- Latin America
- Middle East Africa
- North America
- Rest of World
The report also presents the Pap Smear and HPV clinical significance and current laboratory practice; examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Clinical Significance and Laboratory Practices
B. Diagnostic Testing Instrumentation Review and Market Needs
C. Current and Emerging Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
D. Personal Testing
III. GLOBAL, REGIONAL, COUNTRY MARKET FORECASTS AND SUPPLIERS SHARES
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. COMPETITIVE PROFILES
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic
Leica Biosystems
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Clinical Significance and Laboratory Practices
B. Diagnostic Testing Instrumentation Review and Market Needs
C. Current and Emerging Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
D. Personal Testing
III. GLOBAL, REGIONAL, COUNTRY MARKET FORECASTS AND SUPPLIERS SHARES
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. COMPETITIVE PROFILES
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott
Affymetrix
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujifilm Wako
Fujirebio
Grifols
Hologic
Leica Biosystems
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Siemens Healthineers
Takara Bio
Thermo Fisher and others.
LIST OF TABLES
TABLE 1 PAP SMEAR GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 2 HPV GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 3 GLOBAL MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 4 CHINA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 5 CHINA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 6 CHINA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 7 INDIA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 8 INDIA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 9 INDIA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 1 PAP SMEAR GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 2 HPV GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 3 GLOBAL MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 4 CHINA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 5 CHINA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 6 CHINA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 7 INDIA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 8 INDIA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 9 INDIA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
